Annual General Meeting
The Annual General Meeting (AGM) is Terveystalo’s highest decision-making body. The AGM deals with matters falling within its competence pursuant to the Finnish Limited Liability Companies Act and Terveystalo’s Articles of Association, and any possible other matters. The AGM decides on the matters such as the acceptance of the financial statements and proposed dividend, the release from liability of members of the Board of Directors and the President and CEO, the election of the members of the Board of Directors and the auditors, and the compensation paid to them. Furthermore, an authorization for the Board of Directors to resolve on a share issuance or issuance of other specific rights entitling to shares and amendments to the Articles of Association also require the resolution of the AGM.
The Annual General Meeting is held annually on a date determined by the Board of Directors, within six (6) months of the end of the financial year. An Extraordinary General Meeting is convened when necessary. Each share of Terveystalo entitles the holder to one vote.
The notice to the meeting and other Annual General Meeting documents, including the Board of Directors’ proposals to the Annual General Meeting are disclosed to the shareholders at the latest three weeks before the meeting at the company’s head office and on this website. The notice to the meeting is also disclosed in a stock exchange release.
The members of the Board of Directors, President and CEO, principal auditor and prospective directors attend the General Meeting, unless there are well-founded reasons for their absence.
The minutes of the General Meeting will be available on the company’s website within two weeks of the General Meeting. The resolutions by the General Meeting will be published in a stock exchange release immediately after the meeting.